All the latest about our company
attyloid’s sFIDA technology unveils potential non-invasive biomarker for Alzheimer’s Disease
November 4, 2024We are excited to announce a groundbreaking discovery at attyloid, made possible through our proprietary sFIDA technology, with the potential ...
Novel study highlights role of IAPP oligomerisation in type 2 diabetes progression
August 23, 2024attyloid is thrilled to share exciting findings from a recent study that explored the role of Islet amyloid polypeptide (IAPP) ...
Meet us at BIO International, June 3-6, 2024 in San Diego
May 10, 2024We are excited to announce that attyloid will be participating in this year's BIO International Convention, the world’s largest and ...
attyloid’s sFIDA technology sheds light on the pathophysiological role of Aβ oligomers
May 10, 2024We are very happy to announce that our latest research paper, titled “Aβ oligomers peak in early stages of Alzheimer’s ...
Meet us at Neuro4D Conference
March 19, 2024attyloid is thrilled to announce its sponsorship of the upcoming annual Neuro4D Conference, a cornerstone event dedicated to advancing research ...
attyloid to showcase innovations in biomarker development at AD/PD™ 2024 conference
February 19, 2024We are excited to announce that attyloid will be presenting at the AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s ...
Meet us at the Düsseldorf-Jülich Symposium 2023
December 4, 2023Oliver Bannach, CEO of attyloid, will present at the 5th Düsseldorf-Jülich Symposium on Neurodegenerative Diseases, themed "Amyloid, from early aggregation ...
sFIDA Technology Reveals New Insights into Protein Aggregation in Psychotic Disorders
September 5, 2023In a pioneering study that could have wide-reaching implications for psychiatric research, scientists have employed attyloid’s surface-based Fluorescence Intensity Distribution ...
attyloid’s sFIDA Technology Key in Revealing COVID-19’s Potential Neurodegenerative Impact
August 21, 2023A new study has utilized attyloid's cutting-edge Single Molecule Fluorescence Intensity Distribution Analysis (sFIDA) technology to explore how COVID-19 may ...